Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Stock Could Soar by 120%, According to Wall Street

TheMotleyFool

0 0

This Stock Could Soar by 120%, According to Wall Street: https://g.foolcdn.com/editorial/images/755259/patient-and-doctor-talking.jpg

Analysts on Wall Street sometimes assign one-year price targets to stocks that imply massive upside potential. That's what's happening with Recursion Pharmaceuticals (NASDAQ: RXRX), an innovative biotech. The company's shares are currently changing hands for $7.07 apiece, but the consensus one-year target for the stock is $15.57, which implies that it could rise by about 120% over the next 12 months.

If Recursion Pharmaceuticals can pull that off, the company might be worth considering, but is this target too optimistic? Let's find out.